Cardiovascular Systems ROE 2006-2018 | CSII

Current and historical return on equity (ROE) values for Cardiovascular Systems (CSII) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Cardiovascular Systems ROE for the three months ending December 31, 2018 was 1.28%.
Cardiovascular Systems ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.00B $0.14B 0.75%
2018-09-30 $0.00B $0.13B 0.77%
2018-06-30 $0.00B $0.13B 1.59%
2018-03-31 $-0.00B $0.13B -0.82%
2017-12-31 $-0.00B $0.12B -2.53%
2017-09-30 $-0.00B $0.12B -1.73%
2017-06-30 $-0.00B $0.12B -1.79%
2017-03-31 $-0.01B $0.11B -7.46%
2016-12-31 $-0.03B $0.11B -27.75%
2016-09-30 $-0.05B $0.10B -42.15%
2016-06-30 $-0.06B $0.10B -49.23%
2016-03-31 $-0.06B $0.10B -48.68%
2015-12-31 $-0.05B $0.12B -35.96%
2015-09-30 $-0.04B $0.13B -27.09%
2015-06-30 $-0.03B $0.14B -22.84%
2015-03-31 $-0.03B $0.14B -23.01%
2014-12-31 $-0.03B $0.15B -21.85%
2014-09-30 $-0.04B $0.15B -24.18%
2014-06-30 $-0.04B $0.15B -27.22%
2014-03-31 $-0.03B $0.16B -29.73%
2013-12-31 $-0.03B $0.16B -32.40%
2013-09-30 $-0.03B $0.07B -45.02%
2013-06-30 $-0.02B $0.07B -49.23%
2013-03-31 $-0.02B $0.07B -55.00%
2012-12-31 $-0.02B $0.03B -73.39%
2012-09-30 $-0.02B $0.03B -70.59%
2012-06-30 $-0.02B $0.03B -70.83%
2012-03-31 $-0.01B $0.02B -65.12%
2011-12-31 $-0.01B $0.02B -57.14%
2011-09-30 $-0.01B $0.02B -50.63%
2011-06-30 $-0.01B $0.02B -56.34%
2011-03-31 $-0.01B $0.02B -71.64%
2010-12-31 $-0.02B $0.02B -100.00%
2010-09-30 $-0.02B $0.02B -118.92%
2010-06-30 $-0.02B $0.02B -111.63%
2010-03-31 $-0.03B $0.02B -106.12%
2009-12-31 $0.00B $0.02B 10.53%
2009-09-30 $0.01B $0.03B 43.96%
2009-06-30 $0.00B $0.03B 7.34%
2009-03-31 $-0.01B $0.03B -55.70%
2008-12-31 $-0.06B $0.00B -196.61%
2008-09-30 $-0.06B $0.05B -196.61%
2008-06-30 $-0.06B $0.00B -130.23%
2008-03-31 $0.01B $0.07B 11.35%
2007-12-31 $0.02B $0.00B 35.29%
2007-09-30 $0.02B $0.10B 35.29%
2007-06-30 $0.03B $0.11B 47.43%
2007-03-31 $-0.02B $0.06B -52.17%
2006-12-31 $-0.03B $0.00B -82.64%
2006-09-30 $-0.04B $0.08B -86.86%
2006-06-30 $-0.04B $0.04B -176.84%
2006-03-31 $-0.04B $0.00B -303.70%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.346B $0.217B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Haemonetics (HAE) United States $4.311B 38.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29